Clinical trials
Recruiting Phase 2 Scleroderma, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Artiva Biotherapeutics, Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Galderma R&D | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Paul Szabolcs | 1 |
| Peking University People's Hospital | 1 |
| Robyn T. Domsic, MD, MPH | 1 |
| Scleroderma Research Foundation, Inc. | 1 |
| Stephan Grupp MD PhD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 16 |
| Lung Diseases, Interstitial | 5 |
| Scleroderma, Diffuse | 5 |
| Dermatomyositis | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Myositis | 2 |
| Sjogren's Syndrome | 2 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Antiphospholipid Syndrome | 1 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.